Search Results - "Inflammatory Bowel Diseases"

Evaluation of <it>SLC11A1 </it>as an inflammatory bowel disease candidate gene by Petras Robert E, Cobbs Gary A, Lewis Robert K, Colliver Daniel W, Eichenberger Maurice R, Crawford Nigel PS, Galandiuk Susan

Connect to this object online.

Influence of environmental factors and diet on inflammatory bowel diseases - a review of the literature by Ewelina Wesolek, Kinga Knop-Chodyła, Anna Kochanowska-Mazurek, Zuzanna Piasecka, Aneta Głaz, Karolina Pawelec, Albert Bielaska, Grzegorz Jama

Connect to this object online.

Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease by Guangxi Zhou, Lin Yu, Wenjing Yang, Wei Wu, Leilei Fang, Zhanju Liu

Connect to this object online.

Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation by Rosa Direito, João Rocha, Bruno Sepodes, Maria Eduardo-Figueira

Connect to this object online.

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease by Marzena Komraus, Halina Wos, Sabina Wiecek, Maciej Kajor, Urszula Grzybowska-Chlebowczyk

Connect to this object online.

Contrasting roles of the P2X4 receptor in inflammatory bowel disease by Ronald Sluyter

Connect to this object online.

Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors by Sowon Park, Yunkoo Kang, Hong Koh, Seung Kim

Connect to this object online.

Vitamin D as a predictor of severe course of inflammatory bowel diseases in children by T.V. Sorokman, S.V. Sokolnyk, N.O. Popelyuk, O.V. Makarova

Connect to this object online.

A review of the use of Complementary and Alternative medicines by children with Inflammatory Bowel Disease by Andrew S Day

Connect to this object online.

A case of carbidopa/levodopa associated colitis mimicking inflammatory bowel disease by Michael J. Steel, James Conner, Sandra Nelles, Richard Kirsch

Connect to this object online.

Adalimumab induced psoriasis during the treatment of inflammatory bowel disease - case report by Edyta Lelonek, Magdalena Dębicka, Joanna Maj, Anita Hryncewicz-Gwóźdź, Łukasz Matusiak

Connect to this object online.

Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease by Wang Y, Li C, Wang W, Wang J, Li J, Qian S, Cai C, Liu Y

Connect to this object online.

The role of cGAS in epithelial dysregulation in inflammatory bowel disease and gastrointestinal malignancies by Anna Ramos, Nazih Bizri, Elizabeth Novak, Elizabeth Novak, Kevin Mollen, Kevin Mollen, Sidrah Khan

Connect to this object online.

Beneficial effects of a pharmaceutical care program on outpatients with inflammatory bowel disease by Nathalie de Lourdes Souza Dewulf, Vania dos Santos, Leonardo Régis Leira Pereira, Luiz Ernesto de Almeida Troncon

Connect to this object online.

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin by Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, Wang X, Yu P, Liu W, Ping Y, Sun T, Sang Y, Liu Z, Chen Y, Tao Z

Connect to this object online.

Oral manifestations in inflammatory bowel disease: A cross-sectional study in Isfahan by Faezeh Khozeimeh, Hadi Shakerin, Hamed Daghaghzadeh, Fereshteh Najarzadegan, Zahra Golestannejad, Peyman Adibi

Connect to this object online.

Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies by Yamamoto-Furusho JK

Connect to this object online.

Autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome in inflammatory bowel diseases by Joanna Saganek, Monika Meglicka, Aleksandra Nowakowska, Marcin Osiecki, Jarosław Kierkuś

Connect to this object online.

Multicenter registry of pediatric inflammatory bowel disease from a developing country by Pornthep Tanpowpong, Settapong Jitwongwai, Teera Kijmassuwan, Hansa Sriphongphankul, Seksit Osatakul, Alisara Damrongmanee, Nuthapong Ukarapol, Suporn Treepongkaruna

Connect to this object online.

Impact on the budget of ONLS program of vedolizumab introduction for the treatment of inflammatory bowel disease by S. K. Zyryanov, I. N. Dyakov, A. V. Veselov, V. N. Kashnikov

Connect to this object online.